The global exoskeleton market size was USD 484.8 Million in 2021, and is expected to register a revenue CAGR of 45.9% during the forecast period. A major factor expected to drive market revenue growth is increasing incidence of stroke owing to rapid growth in elderly population across the globe. Rising medical device adoption rates in various industries such as car, military, defense, and construction are one of the primary drivers behind the market revenue growth. Furthermore, rising number of Spinal Cord Injuries (SCI) is expected to drive demand in global markets. According to the National Spinal Cord Injury Statistical Center (NSCISC), there were 17,730, 17,810, and 10,9000 SCI cases in 2022, 2020, and 2021, respectively. Furthermore, roughly 296,000 Americans have SCIs of some kind.
Moreover, as the global population with impairments grows, there is a rise in the need for robotic rehabilitation equipment. Musculoskeletal injuries and disorders such as Repetitive Strain Injury (RSI), Cumulative Trauma Disorders (CTD), and Occupational Overuse Syndromes (OOS) are expected to drive revenue growth of the market. According to World Health Organization statistics from February 2021, 1.71 billion people worldwide suffer from musculoskeletal disorders. According to data released by the Health and Safety Executive (HSE) in November 2020, 480,000 employees in the U.K. suffered from work-related musculoskeletal ailments in 2022-20, with a rate of 2,020 cases per 100,000 workers in the construction industry.
In addition to it, exoskeletons are being used to help military troops with physical deformities as a result of battle traumas and are used in new ways to help people overcome health problems and improve athletic capabilities. Exoskeleton can assist humans in walking, standing, and moving heavy objects, as well as contribute to health care. According to scientists and experts, mechanical exoskeletons can keep the elderly active, independent, and healthy for a longer period of time thereby, mitigate the effects of a variety of disabilities, including paralysis, fatigue, and muscular dystrophy. Over the forecast period, customization in the exoskeleton product line is expected to drive revenue growth of the market. However, poor purchasing power, limited access to technologically advanced commodities, and low per capita income have hampered adoption of exoskeletons in developing economies, further restricting total revenue growth of the market.
Request a Sample@ https://qyresearchmedical.com/sample/119100
Driver: Increase in demand for robotic rehabilitation in the healthcare industry
Robot-assisted therapy systems are getting familiar in rehabilitation as they provide a number of benefits, including conducting repetitive motions during goal-directed activities, monitoring different physiological and functional parameters during rehabilitation exercises, enhancing motivation, and aiding with home exercises and training. An increase in the number of people with physical restrictions, particularly among the elderly, and usage of exoskeletons for such purposes has contributed to the market revenue growth. According to the Japan Statistics Bureau, the population aged above 65 in 2022 was 35.89 million, accounting for 28.4% of the total population (i.e., one out of every four people). In addition, on 5 January 2022, Roam Robotics, which is a San-Francisco based start-up along with the San Francisco VA Health Care System and the Northern California Institute for Research and Education launched ‘smart knee’ bracing, which is capable of helping patients with knee osteoarthritis. The device is considered a class I device by the Food and Drug Administration (FDA), to assist knee disorders in patients where traditional pain medications or steroid injections are considered as poor treatment options.
Restraint: Regulatory permissions for exoskeleton medical uses is challenging
User safety and device dependability are the primary issues in the development of medical devices. During product testing, manufacturers’ technical design talents and expertise are crucial. Exoskeletons designed for healthcare purposes must be thoroughly evaluated owing to the fact that a medical equipment malfunction could be lethal. In addition, only a few standards directly apply to the exoskeleton sector at the moment. The FDA recognizes ISO standards that apply to relevant enterprises, and only things that have received regulatory approval can be sold to customers. Apart from this, according to reports published on 29 September 2020, European Parliament has taken strict regulatory resolutions against direct usage of robots and artificial intelligence considering the fact that interaction is expected to raise several ethical, legal, and societal concerns.
The pandemic had a negative impact on the elderly population, who use exoskeletons the most as owing to COVID-19, all rehabilitation facilities were closed or only partially accessible, and people were unable to reach them even in an emergency. Similarly, training and delivery were prohibited. Post COVID-19 pandemic, the market is regaining momentum, and rehabilitation institutes are rescheduling all of the appointments that were canceled during the pandemic. According to a research article published by the Department of Complex Systems, Artificial Intelligence (AI) & Robotics, France in 2021 titled ‘Biomechanical effects of using a passive back support exoskeleton during prone-positioning maneuver: A pilot study’ stated that during the COVID-19 pandemic, ICU clinicians had to do Prone-positioning (PP) on a significant number of intubated patients with Acute Respiratory Distress Syndrome (ARDS) several times a day. The researchers observed that using the Laevo might assist in reducing musculoskeletal strain on the lower back during prone positional movements without causing any significant negative side effects or needing any adjustments to the practice. As a result, exoskeletons were in high demand during the epidemic.
Based on mobility, global exoskeleton market has been segmented into mobile and stationary. In 2021, mobile segment accounted for a larger revenue share in 2021. The primary goal of exoskeletons is to provide assistance to persons who have lost mobility, which can only be achieved with mobile exoskeletons. Mobile exoskeletons are in high demand than stationary exoskeletons. Individuals who have lost complete lower limb movement owing to illnesses such as spinal cord injury benefits from lower extremity exoskeletons developed for human locomotion assistance. ReWalk, Rex, Indego, Ekso, HAL, Atlas, and other mobile exoskeleton technologies for persons with lower-limb mobility disabilities are among the most commonly used. Apart from this, rehabilitation robots can relieve therapists’ workload, provide data detection during training, and facilitate quantitative recovery evaluation in a controlled and reproducible manner. Several market participants are helping to drive the market upward. For instance, a healthcare start-up focused on rehabilitation and assistive robots, Astrek Innovations, announced on 11 March 2021, that they are at the last stage of product development and plans to begin user trials in the second quarter of 2021. Unik Exosuit is a motorized wearable robot from Astrek that can assist people with lower limb problems with gait training and exercise.
Based on anatomy, the global exoskeleton market has been segmented into lower extremities, upper extremities, and full body. Over the forecast period, the lower extremities segment is expected to register a steady revenue growth rate. The majority of exoskeletons are designed to help patients who have mobility issues. The most common mobility issues are those that affect the lower half of the body. As a result, demand for lower-body exoskeletons is relatively high. Exoskeletons for the lower body are used to help people with disabilities move around. They can also be used for a variety of other things, such as supporting soldiers on the battlefield.
Over the forecast period, the upper extremities segment is also expected to grow at faster revenue CAGR. This is owing to the benefits of employing an exoskeleton for the upper extremity, which includes post-stroke rehabilitation, musculoskeletal and neurological problems, and supporting physically challenged people with daily activities. For example, Ekso Bionics Holding Inc. developed EksoUE on 24 July 2022, which is utilized to assist upper extremity rehabilitation.
Based on end-use, the global exoskeleton market has been segmented into healthcare, military, industrial, and others. In 2021, healthcare segment accounted for the largest revenue share in 2021. Increase in prevalence of SCI, as well as the associated increase in treatment rates, are expected to drive revenue growth of the segment. Furthermore, greater awareness of technologically advanced systems, as well as increasing number of FDA approvals for medical exoskeletons, are expected to increase demand for exoskeleton in the healthcare industry.
Over the forecast period, the military and defense segment is expected to register a steady revenue growth rate. Exoskeletons can help soldiers on the battlefield lift heavier weapons, move quicker, and cover more ground; as a result, governments of various countries across the globe are planning to use exoskeletons in military and defense applications to improve national security. Exoskeleton innovations are a major driver of revenue growth in the military and defense sectors. Exoskeletons for military applications are being improved in efficiency via the introduction of new technologies, which is expected to drive revenue growth in the segment. Additionally, researchers are working to develop smart exoskeleton technologies for usage with the upper body.
In 2021, the Asia-Pacific exoskeleton market accounted for the largest market revenue share. The regional market is expected to increase owing to availability of a large number of patients in need of exoskeletons for rehabilitation. Furthermore, expanding healthcare infrastructure, combined with rising government funding for medical equipment, is increasing exoskeleton use, resulting in market revenue growth. Certain companies in Japan are offering exoskeletons to workers to eliminate labor shortage issues and encourage older workers to stay on job. Revenue growth of the market in this region is expected to be driven by economic expansion in countries such as India, China, and Japan, as well as increased initiatives by governments to improve healthcare infrastructure.
Market in North America accounted for largest revenue share in 2021, owing to growing disabled population, significant spending in the healthcare research sector by commercial and government organizations, availability of technologically advanced medical equipment, and growing collaborations between companies and research organizations for development of exoskeleton technologies. Additional funding and grants for technologically advanced products from companies, increased purchasing power parity, increased global augmentation in the military and industrial sectors, and presence of large companies offering funds and grants for the development of technologically advanced products are contributing to revenue growth of the market. Sarcos, for example, raised USD 40 million for a Series C funding round led by Rotor Capital in September 2020. The money is expected to expand the commercial manufacturing of Guardian XO products.
Europe is expected to register a moderate revenue growth rate during the forecast period, owing to developments in robotic technology, which integrates human labor with the Industrial Internet of Things (IIoT). For instance, on 14 December 2020, German Bionic generated USD 20 million from Samsung for technology in exoskeleton to supercharge human labor in a Series A funding. Furthermore, demand for building robots to enhance humans has increased as a result of technological breakthroughs in cloud computing, smaller processors for hardware, and AI.
Competitive landscape of the global exoskeleton market is moderately fragmented with several key players operating on global and regional levels. Key players are engaged in platform development and strategic alliances to expand their respective portfolios and gain a robust footing in global market. Some of the major companies included in the global market report are Lockheed Martin Corporation, ReWalk Robotics, Parker Hannifin Corp., Rex Bionics Ltd., Ekso Bionics, Cyberdyne Inc., ATOUN Inc., BIONIK, Hocoma, Honda Motor Co. Ltd., Wandercraft, and Ottobock.
- On 31 March 2021, Ottobock launched the Paexo Shoulder Jacket, Paexo Cool Sleeve, and Paexo Thumb Slim at the Hannover Messe Digital Edition 2021 event. These gadgets offer great relaxation to the body during demanding activities such as overhead labor or package lifting.
- On 20 August 2020, Ekso Bionics Holdings Inc., an industry leader in exoskeleton technology for medical and industrial use, unveiled EVOTM, an endurance-boosting assistive upper-body exoskeleton that reduces the stress of repeated labor. Building on the Company’s trailblazing EksoVest technology, EVO’s innovative design is the next step in the evolution of industrial exoskeletons.
Segments Covered in the report
This report offers historical data and forecasts revenue growth at a global, regional, and country-level, and provides analysis of market trends in each of sub-segments from 2022 to 2030. For the purpose of this report, Reports and Data has segmented global exoskeleton market based on product type, component type, anatomy type, mobility, indication type, end-use, and region:
Exoskeleton Market Report Scope
Segments covered By Product Type Outlook, Component Type Outlook, Mobility Outlook, Anatomy Type Outlook, Indication Type Outlook, End-use Outlook, Regional Outlook
By Product Type Outlook
By Component Type Outlook
By Anatomy Type Outlook
By Mobility Outlook
By Indication Type Outlook
By End-use Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119100/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: